We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov Menu

Glycemic Response to Road Cycling in Type 1 Diabetes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2011 by Team Type 1, Inc..
Recruitment status was:  Active, not recruiting
ClinicalTrials.gov Identifier:
First Posted: July 21, 2011
Last Update Posted: July 21, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Team Type 1, Inc.
The purpose of this study is to assess the glycemic response to cycling road races (using continuous glucose monitoring ) in elite athletes with type 1 diabetes and non-diabetic controls. The investigators will also assess the relationship between power/work during cycling (using a power meter) and the subject's glucose profile.

Type 1 Diabetes

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Pilot Study Assessing the Glycemic Response and Its Relationship to Performance During Road Cycling in Elite Athletes With Type 1 Diabetes and Non-Diabetic Controls

Resource links provided by NLM:

Further study details as provided by Team Type 1, Inc.:

Estimated Enrollment: 30
Study Start Date: May 2011
Estimated Study Completion Date: August 2011
Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Professional cyclists on TeamType 1 cycling teams

Inclusion Criteria:

  • ≥18 years of age
  • A1C ≤8.0% if diagnosed with type 1 DM

Exclusion Criteria:

  • If diagnosed with type 1 diabetes, has had recurrent severe hypoglycemia (greater than 2 episodes in previous 6 months requiring assistance by a third party)
  • Has any medical condition or medical history that may affect successful completion of the study and/or personal well-being (as assessed by the PI)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01398826

Sponsors and Collaborators
Team Type 1, Inc.
Principal Investigator: Juan P Frias, MD Team Type 1, Inc.
  More Information

Responsible Party: Juan Pablo Frias, MD, TeamType 1
ClinicalTrials.gov Identifier: NCT01398826     History of Changes
Other Study ID Numbers: TT1-001
First Submitted: July 19, 2011
First Posted: July 21, 2011
Last Update Posted: July 21, 2011
Last Verified: July 2011

Keywords provided by Team Type 1, Inc.:
Type 1 Diabetes
Continuous glucose monitoring

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases